This page is a living tracker of every retatrutide clinical trial, from Phase 1 through the ongoing Phase 3 TRIUMPH program
Background and aims: Once-weekly semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) approved for the treatment of type 2 diabetes (T2D), consistently demonstrated superior HbA 1c and body weight reductions vs placebo and active comparators in the SUSTAIN clinical trials
Xu, C., Xu, L., Yu, C., Miao, M
The molecular mechanism of rotenone-induced -synuclein aggregation: EMPHASIZING the role of the calcium/GSK3 pathway
Optional: you can absolutely mix it with Wel just a lil obsessed with leaves so i been out of my favorite teas, and decided to try some new one, and BAY BEEEE, let me tell youuuuu